McGough and colleagues found that over 40% of adults under 65 with private insurance could qualify for a GLP-1 drug under previous Food and Drug Administration (FDA) indications accounting for obesity and type 2 diabetes
It is important to clarify that GLP-1 medications do not directly "attack" muscle tissue
Boima V, Agyekum AB, Ganatra K, Agyekum F, Kwakyi E, Inusah J, et al
Additionally, long-term, high-dose supplementation may occasionally affect your bodys zinc levels, so maintaining a balanced diet is key
(55) found that the blood lipocalin-2 (LCN2) and serum amyloid A (SAA) levels may be associated with a type 17 asthma subtype, which are steroid-resistant IL-17A target genes in airway cells, and IL-17AAct1/CEBPB axis is an important regulatory mechanism of LCN2 and SAA